Systems Analysis and Improvement Approach to Prevent TB
NCT06314386 · Status: ENROLLING_BY_INVITATION · Phase: NA · Type: INTERVENTIONAL · Enrollment: 19560
Last updated 2025-05-06
Summary
This randomized trial uses the evidence-based Systems Analysis and Improvement Approach (SAIA) adapted for tuberculosis (SAIA-TB) to assess the comprehensive tuberculosis (TB) care cascade across 16 clinics in rural Eastern Cape, South Africa to improve patient outcomes. The aims of this study are to:
* Evaluate the effectiveness of SAIA-TB use in clinics on TB cascade outcomes for TB patients and with high-risk contacts
* Determine the drivers of SAIA-TB implementation success or failure across clinics
The investigators hypothesize that SAIA-TB implementation will lead to a 20% increase in each of: TB screening, TB preventive treatment initiation, and TB disease treatment initiation during the 18-month intervention period.
Conditions
- Tuberculosis
- TPT
- TB - Tuberculosis
Interventions
- OTHER
-
Systems Analysis and Improvement Approach for TB (SAIA-TB)
The Systems Analysis and Improvement Approach for TB (SAIA-TB) is a five-step systems analysis and iterative improvement cycle intervention which will be implemented by clinic staff with support from study personnel in intervention clinics. Components of the intervention include TB cascade analysis, patient flow mapping and continuous quality improvement, aimed to incrementally optimize TB screening, evaluation, diagnosis, TB preventive therapy and TB disease treatment initiation, successful treatment, and TB-free survival among the population at the intervention clinics.
Sponsors & Collaborators
-
National Institutes of Health (NIH)
collaborator NIH -
Boston University
collaborator OTHER - collaborator OTHER
-
Medical Research Council, South Africa
collaborator OTHER -
National Institute of Nursing Research (NINR)
collaborator NIH -
Boston College
lead OTHER
Principal Investigators
-
Brittney J van de Water, PhD · Boston College
Study Design
- Allocation
- RANDOMIZED
- Purpose
- HEALTH_SERVICES_RESEARCH
- Masking
- NONE
- Model
- CROSSOVER
Eligibility
- Min Age
- 0 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-02-06
- Primary Completion
- 2028-02-29
- Completion
- 2029-02-28
Countries
- South Africa
Study Locations
More Related Trials
-
Point-of-care Triage Test for Active Tuberculosis
NCT04232618 ·Status: UNKNOWN
-
Preventing Childhood Tuberculosis in Lesotho (PREVENT Study)
NCT02662829 ·Status: COMPLETED ·Phase: NA
-
Improving TB Diagnosis and Treatment Through Basic, Applied and Health Systems Research
NCT03356925 ·Status: COMPLETED ·Phase: NA
-
Promoting Engagement in the Drug Resistant TB/HIV Care Continuum in South Africa
NCT03162107 ·Status: COMPLETED
-
A Nurse Case Management Intervention to Improve MDR-TB/HIV Co-Infection Outcomes
NCT02129244 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Study to Evaluate H56:IC31 in Preventing Rate of TB Recurrence
NCT03512249 ·Status: COMPLETED ·Phase: PHASE2
-
Validating the Use of Blood Transcriptomic Signatures for the Diagnosis of Active Pulmonary Tuberculosis
NCT04995406 ·Status: COMPLETED
-
Bioaerosol Sampling in Suspected Pulmonary Tuberculosis
NCT04241809 ·Status: COMPLETED
-
The Effect of Telephone Follow-up and Training on Treatment Adherence in Tuberculosis Patients and Contacts
NCT05202431 ·Status: COMPLETED ·Phase: NA
-
Post-Trial Tuberculosis Case Finding: A Substudy of CoVPN 3008
NCT06585683 ·Status: COMPLETED
-
Cali Sin Tos Aim 2
NCT06338462 ·Status: COMPLETED ·Phase: NA
-
Phase 2a ID93 + GLA-SE Vaccine Trial in TB Patients After Treatment Completion
NCT02465216 ·Status: COMPLETED ·Phase: PHASE2
-
Choice Architecture Based TB Preventive Therapy Prescribing
NCT04466293 ·Status: COMPLETED ·Phase: NA
-
Enhancing the Public Health Impact of Latent Tuberculosis (TB) Infection Diagnosis and Treatment
NCT02810678 ·Status: COMPLETED ·Phase: NA
-
Bring BPaL2Me Trial Comparing Nurse-Led RR-TB Treatment to Physician-Led RR-TB Treatment
NCT05671718 ·Status: RECRUITING ·Phase: NA
-
Study of Limited Versus Continuous Isoniazid Tuberculosis Preventive Therapy in HIV-infected Persons in Botswana
NCT00164281 ·Status: COMPLETED ·Phase: PHASE4
-
TB Host Directed Therapy
NCT02968927 ·Status: UNKNOWN ·Phase: PHASE2
-
Effectiveness of Public Health Model of Latent Tuberculosis Infection Control for High-Risk Adolescents
NCT00233168 ·Status: COMPLETED ·Phase: NA
-
Improving the Diagnostic of Tuberculosis
NCT02861768 ·Status: COMPLETED ·Phase: NA
-
Optimal Treatment Duration for Radiographically Apparent, Bacteriologically Unconfirmed TB, Identified Through Active Case Finding (RADIO-TB Trial)
NCT07163143 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Community-based Tuberculosis Tracing and Preventive Therapy
NCT03832023 ·Status: COMPLETED ·Phase: NA
-
A Multiple Ascending Dose Study With a Dose Formulation Comparison Cohort to Evaluate the Safety, Tolerability, and Pharmacokinetics of TBA-354 in Healthy Adult Subjects
NCT02606214 ·Status: TERMINATED ·Phase: PHASE1
-
Patient Centered Intervention to Prevent Tuberculosis Among Children Under Five Years Old
NCT03881228 ·Status: COMPLETED ·Phase: NA
-
Promoting Engagement in the Drug Resistant TB-HIV Care Continuum in South Africa PRAXIS Study
NCT04032730 ·Status: COMPLETED ·Phase: NA
-
The Correlate of Risk Targeted Intervention Study
NCT02735590 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3